Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3655060
Max Phase: Preclinical
Molecular Formula: C37H49FN2O2S
Molecular Weight: 604.88
Molecule Type: Small molecule
Associated Items:
ID: ALA3655060
Max Phase: Preclinical
Molecular Formula: C37H49FN2O2S
Molecular Weight: 604.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)c1ccc(CC(C)(C)N2CCc3cc(S(=O)(=O)Nc4ccc(CCCC5CCCC5)cc4F)ccc3C2)cc1
Standard InChI: InChI=1S/C37H49FN2O2S/c1-36(2,3)32-17-13-29(14-18-32)25-37(4,5)40-22-21-30-24-33(19-16-31(30)26-40)43(41,42)39-35-20-15-28(23-34(35)38)12-8-11-27-9-6-7-10-27/h13-20,23-24,27,39H,6-12,21-22,25-26H2,1-5H3
Standard InChI Key: LGCKNNFUYPBHPG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 604.88 | Molecular Weight (Monoisotopic): 604.3499 | AlogP: 8.82 | #Rotatable Bonds: 10 |
Polar Surface Area: 49.41 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.16 | CX Basic pKa: 8.99 | CX LogP: 9.21 | CX LogD: 8.61 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.25 | Np Likeness Score: -1.14 |
1. (2015) Nitrogen-containing condensed heterocyclic compound, |
Source(1):